pimagedine has been researched along with lipid a in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| György, K; Papp, JG; Parratt, JR; Rastegar, MA; Végh, A | 1 |
| Elliott, GT; Hata, K; Przyklenk, K; Whittaker, P | 1 |
| Das, DK; Elliott, GT; Engelman, DT; Engelman, RM; Maulik, N; Rousou, JA; Sato, M; Yoshida, T | 1 |
| de Ridder, M; Monsaert, C; Sermeus, AB; Storme, GA; Van den Berge, DL; Verovski, VN; Wauters, N | 1 |
| Darville, MI; De Ridder, M; Eizirik, DL; Monsaert, C; Storme, GA; Van Den Berge, DL; Verovski, VN | 1 |
5 other study(ies) available for pimagedine and lipid a
| Article | Year |
|---|---|
Delayed protection against ventricular arrhythmias by monophosphoryl lipid-A in a canine model of ischaemia and reperfusion.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Arterial Occlusive Diseases; Coronary Vessels; Disease Models, Animal; Dogs; Enzyme Inhibitors; Female; Guanidines; Heart Ventricles; Hemodynamics; Lipid A; Male; Meclofenamic Acid; Myocardial Ischemia; Myocardial Reperfusion Injury; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Prostaglandin-Endoperoxide Synthases; Severity of Illness Index; Tachycardia, Ventricular; Time Factors; Ventricular Fibrillation | 1999 |
Monophosphoryl lipid A: a novel nitric oxide-mediated therapy to attenuate platelet thrombosis?
Topics: Adjuvants, Immunologic; Analysis of Variance; Animals; Coronary Circulation; Coronary Thrombosis; Dogs; Enzyme Inhibitors; Guanidines; Hemodynamics; Lipid A; Nitric Oxide; Platelet Aggregation | 2000 |
Preconditioning of swine heart with monophosphoryl lipid A improves myocardial preservation.
Topics: Animals; Enzyme Induction; Enzyme Inhibitors; Guanidines; Hemodynamics; Ischemic Preconditioning, Myocardial; Lipid A; Myocardial Infarction; Myocardial Reperfusion Injury; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; RNA, Messenger; Swine | 2000 |
Lipid a radiosensitizes hypoxic EMT-6 tumor cells: role of the NF-kappaB signaling pathway.
Topics: Cell Hypoxia; Cell Line, Tumor; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Guanidines; Humans; Isoenzymes; Lipid A; Membrane Proteins; NF-kappa B; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Radiation-Sensitizing Agents; Signal Transduction; Sulfonamides | 2003 |
Macrophages enhance the radiosensitizing activity of lipid A: a novel role for immune cells in tumor cell radioresponse.
Topics: Animals; Cell Hypoxia; Cell Line, Tumor; Culture Media, Conditioned; Enzyme Activation; Enzyme Inhibitors; Female; Guanidines; Interferon-gamma; Interleukins; Lipid A; Macrophage Activation; Macrophages; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Radiation Tolerance; Tumor Necrosis Factor-alpha | 2004 |